SCOPUS 정보 검색 플랫폼

Volumn 58, Issue 2, 2001, Pages 249-254

Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease

(12) Rascol, O a Nutt, J G a Blin, O a Goetz, C G a Trugman, J M a Soubrouillard, C a Carter, J H a Currie, L J a Fabre, N a Thalamas, C a Giardina, W J a Wright, S a

a UNIVERSITÉ DE TOULOUSE (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADROGOLIDE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; LEVODOPA; PRODRUG; ANTIPARKINSON AGENT; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; PYRIDINE DERIVATIVE; TETRALIN DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSKINESIA; FRANCE; HUMAN; MULTICENTER STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; ST SEGMENT DEPRESSION; UNITED STATES; ADULT; AGED; FEMALE; MALE; MIDDLE AGED;

ADULT; AGED; ANTIPARKINSON AGENTS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PRODRUGS; PYRIDINES; RECEPTORS, DOPAMINE D1; TETRAHYDRONAPHTHALENES;

EID: 0034745615 PISSN: 00039942 EISSN: None Source Type: Journal
DOI: 10.1001/archneur.58.2.249 Document Type: Article

Times cited : (136)

References (29)

1
- 0025355032
- Levodopa-induced dyskinesias: Review, observations, and speculations
- (1990) Neurology , vol.40 , pp. 340-345
- Nutt, J.G.¹

2
- 0030895023
- The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys
- (1997) Mov Disord , vol.12 , pp. 148-158
- Rioux, L.¹ Frohna, P.A.² Joyce, J.N.³ Schneider, J.S.⁴

3
- 0022492455
- 3H] spiperone binding
- (1986) Brain Res , vol.379 , pp. 294-299
- Bédard, P.J.¹ Di Paolo, T.² Falardeau, P.³ Boucher, R.⁴

4
- 0025194699
- 2 agonists in MPTP-treated primates: Functional implications for Parkinson's disease
- (1990) Neurology , vol.40 , pp. 927-933
- Boyce, S.¹ Rupniak, N.M.J.² Steventon, M.J.³ Iversen, S.D.⁴

5
- 18244424280
- 1 receptor agonist, A-86929: An acute study in parkinsonian levodopa-primed monkeys
- (1997) Neurology , vol.49 , pp. 421-426
- Grondin, R.¹ Bédard, P.J.² Britton, D.R.³ Shiosaki, K.⁴

6
- 15844379678
- 1 receptor agonist: In vitro characterization and effects in animal models of Parkinson's disease
- (1996) J Pharmacol Exp Ther , vol.276 , pp. 150-160
- Shiosaki, K.¹ Jenner, P.² Asin, K.E.³

7
- 0029132232
- 1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl pro-drug (ABT-431)
- (1995) J Med Chem , vol.38 , pp. 3445-3447
- Michaelides, M.R.¹ Hong, Y.² Di Domenico, S.³

8
- 0030973503
- 1 receptor agonist A-86929 maintains efficacy with repeated treatment in rodent and primate models of Parkinson's disease
- (1997) J Pharmacol Exp Ther , vol.281 , pp. 454-459
- Asin, K.E.¹ Domino, E.F.² Nikkel, A.³ Shiosaki, K.⁴

9
- 0033019985
- 1 receptor agonist pro-drug, has efficacy in Parkinson's disease
- (1999) Ann Neurol , vol.45 , pp. 736-741
- Rascol, O.¹ Blin, D.² Thalamas, C.³

10
- 0023898945
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease
- (1988) J Neurol Neurosurg Psychiatry , vol.51 , pp. 745-752
- Gibb, W.R.G.¹ Lees, A.J.²

11
- 0026515731
- Core Assessment Program for Intracerebral Transplantations (CAPIT)
- (1992) Mov Disord , vol.7 , pp. 2-13
- Langston, J.W.¹ Widner, H.² Goetz, C.G.³

12
- 0028084737
- Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
- (1994) Mov Disord , vol.9 , pp. 2-12
- Marconi, R.¹ Lefebvre-Caparros, D.² Bonnet, A.M.³ Vidailhet, M.⁴ Dubois, B.⁵ Agid, Y.⁶

13
- 0000224448
- Unified Parkinson's Disease Rating Scale
- Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. New York, NY: Macmillan Publishing Co Inc
- (1987) , vol.2 , pp. 153-163
- Fahn, S.¹ Elton, R.²

14
- 0024323166
- A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease
- (1989) Neurology , vol.39 , pp. 856-858
- Tsui, J.K.C.¹ Wolters, E.C.² Peppard, R.F.³ Calne, D.B.⁴

15
- 0026747624
- 1 agonist, CY 208-243, in de novo patients with Parkinson's disease
- (1992) Mov Disord , vol.7 , pp. 239-243
- Emre, M.¹ Rinne, U.K.² Rascol, A.³ Lees, A.⁴ Agig, Y.⁵ Lataste, X.⁶

16
- 0023032280
- 1 dopamine receptor agonist treatment of Parkinson's disease
- (1987) J Neural Transm , vol.68 , pp. 41-50
- Braun, A.¹ Fabbrini, G.² Mouradian, M.M.³ Serrati, C.⁴ Barone, P.⁵ Chase, T.N.⁶

17
- 0025919702
- 2 agonists and antagonists on dyskinesias produced by L-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys
- (1991) J Pharmacol Exp Ther , vol.259 , pp. 409-413
- Gomez-Mancilla, B.¹ Bédard, P.J.²

18
- 0025827767
- 1 agonist, reduces MPTP-induced parkinsonism in monkeys
- (1991) Eur J Pharmacol , vol.199 , pp. 389-391
- Taylor, J.R.¹ Lawrence, M.S.² Redmond D.E., Jr.³

19
- 0031726938
- 1 receptor agonist dihydrexidine in Parkinson's disease
- (1998) Clin Neuropharmacol , vol.21 , pp. 339-343
- Blanchet, P.J.¹ Fang, J.² Gillespie, M.³

20
- 0018382817
- Long-term treatment of Parkinson's disease with bromocriptine
- (1979) J Neurol Neurosurg Psychiatry , vol.42 , pp. 143-150
- Rascol, A.¹ Guiraud, B.² Montastruct, J.L.³ David, J.⁴ Clanet, M.⁵

21
- 0019865234
- Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease
- (1981) J Neurol Neurosurg Psychiatry , vol.44 , pp. 1020-1023
- Lees, A.J.¹ Stern, G.M.²

22
- 0021876679
- Combined bromocriptine-levodopa therapy early in Parkinson's disease
- (1985) Neurology , vol.35 , pp. 1196-1198
- Rinne, U.K.¹

23
- 0028630805
- A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: A five year follow up
- (1994) J Neurol Neurosurg Psychiatry , vol.57 , pp. 1034-1038
- Montastruc, J.L.¹ Rascol, O.² Senard, J.M.³ Rascol, A.⁴

24
- 0025144231
- 2 receptor-mediated function: Behavioural indices
- (1990) Eur J Pharmacol , vol.186 , pp. 79-86
- Murray, A.M.¹ Waddington, J.L.²

25
- 0027324013
- Suppression of dyskinesias in advanced Parkinson's disease, II: Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptoms
- (1993) Neurology , vol.43 , pp. 1551-1555
- Bennett, J.P.¹ Landow, E.R.² Schuh, L.A.³

26
- 0030941117
- Low-dose clozapine improves dyskinesias in Parkinson's disease
- (1997) Neurolog , vol.48 , pp. 658-662
- Durif, F.¹ Vidailhet, M.² Assal, F.³ Roche, C.⁴ Bonnet, A.M.⁵ Agid, Y.⁶

27
- 0027496673
- 2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys
- (1993) J Pharmacol Exp Ther , vol.267 , pp. 275-279
- Blanchet, P.¹ Bédard, P.J.² Britton, D.R.³ Kebabian, J.W.⁴

28
- 0023711041
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II
- (1988) Ann Neurol , vol.24 , pp. 372-378
- Mouradian, M.M.¹ Juncos, J.L.² Fabbrini, G.³ Schlegel, J.⁴ Bartko, J.J.⁵ Chase, T.N.⁶

29
- 0024347984
- Pathogenesis of dyskinesias in Parkinson's disease
- (1989) Ann Neurol , vol.25 , pp. 523-526
- Mouradian, M.M.¹ Heuser, I.J.E.² Baronti, F.³ Fabbrini, G.⁴ Juncos, J.L.⁵ Chase, T.N.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.